Thus, as an adaptive response, most cancer cells show a downregulation or loss of ALDH1L1 [192,193], which results in an increased pool of 10-formyl-THF, supporting enhanced nucleotide biosynthesis and tumor progression. This evidence concerns the gene ALDH1L1 and neoplasm.